Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report) is scheduled to be announcing its earnings results on Thursday, February 8th. Anebulo Pharmaceuticals (NASDAQ:ANEB – Get Free Report) last announced its quarterly earnings data on Tuesday, November 14th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.01. […]
10.02.2023 - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse (the “Company” or “Anebulo”), today announced financial .
09.09.2022 - Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse (the “Company” or “Anebulo”), today announced financial .